Literature DB >> 16988520

"Nothing new": responses to the introduction of antiretroviral drugs in South Africa.

Mickey Chopra1, Carl Kendall, Zelee Hill, Nikki Schaay, Lungiswa L Nkonki, Tanya M Doherty.   

Abstract

Interviews conducted in South Africa found that awareness of antiretroviral therapy was generally poor. Antiretroviral drugs were not perceived as new, but one of many alternative therapies for HIV/AIDS. Respondents had more detailed knowledge of indications, effects and how to access alternative treatments, which is bolstered by the active promotion and legitimization of alternative treatments. Many expressed a lack of excitement about the introduction of antiretroviral therapy, and little change in their attitudes concerning the epidemic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988520     DOI: 10.1097/01.aids.0000247120.12327.6b

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  South Africa's national response to HIV and AIDS treatment: popular media's perspective.

Authors:  Adamson S Muula
Journal:  Croat Med J       Date:  2008-02       Impact factor: 1.351

2.  Traditional healing, biomedicine and the treatment of HIV/AIDS: contrasting south african and native American experiences.

Authors:  Adrian Flint
Journal:  Int J Environ Res Public Health       Date:  2015-04-20       Impact factor: 3.390

3.  Antiretroviral treatment knowledge and stigma--implications for programs and HIV treatment interventions in rural Tanzanian populations.

Authors:  Abela Mpobela Agnarson; Francis Levira; Honorati Masanja; Anna Mia Ekström; Anna Thorson
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

4.  Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa.

Authors:  Karl Peltzer; Natalie Friend-du Preez; Shandir Ramlagan; Henry Fomundam
Journal:  BMC Public Health       Date:  2008-07-24       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.